Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Baxter and GSK H1N1 Vaccines in Children
NCT00980850Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2009
- Primary completion
- Dec 2009
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza A/H1N1 (H1N1), sponsored by University of Oxford. Started Sep 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00980850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980850.